Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 1,59 € (+45,87 %). Medianen er 1,59 € (+45,87 %).

Køb
  5
Behold
  1
Sælg
  1

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Aemetis reports Q2 revenue up 20% as RNG and ethanol projects drive results

    Aemetis posted Q2 2026 revenue of $62.7 million, up 20% year‑over‑year, with operating income improving to $5.8 million and net loss narrowing to $9.4 million; adjusted EBITDA rose to $9.7 million. Section 45Z production tax credits contributed $8.6 million and recent California LCFS pathway approvals materially increase the value of dairy RNG sales. Management highlighted near‑term milestones including two additional dairy digesters, completion of an MVR energy‑efficiency project at the Keyes ethanol plant expected to boost annual cash flow by about $32 million, doubled corn oil recovery capacity, and India biodiesel allocations expected to generate roughly $17 million in revenue. » Mere på finance.yahoo.com


  • Aemetis cuts loss in Q2 2026 but misses revenue forecast

    Aemetis reported Q2 2026 revenue growth of 20% to $62.7 million, but came in about 10.3% below analysts’ expectations. Adjusted loss per share improved to a loss of $0.13 (expected -$0.26) and adjusted EBITDA turned positive at $9.7 million; operating income rose to $5.8 million. The company highlighted liquidity gains from Section 45Z tax credits, but cites only $1 million in cash, high debt and dependence on regulatory credits as risks; the MVR project and LCFS/India businesses are expected to strengthen future cash flows. » Mere på de.investing.com


  • Aemetis reports biodiesel supply contract for India worth about $17 million

    Aemetis shares rose after its subsidiary Universal Biofuels secured supply contracts worth about $17 million. Universal Biofuels is to deliver more than 18 million liters of biodiesel within three months to three state oil marketing companies in India, supporting the national biofuel strategy. The unit operates a plant in Kakinada with an annual capacity of around 80 million gallons and uses a proprietary enzymatic process; additional supply orders are expected before the end of 2026. Universal Biofuels is evaluating expansion opportunities in India, including biogas from dairy waste, ethanol, a sustainable aviation fuel project and a possible IPO. » Mere på de.investing.com


  • Aemetis disappoints with Q1 results, shares fall about 20%

    Aemetis reported Q1 2026 EPS of -$0.33 and revenue of $54.6 million, missing both EPS and revenue estimates by a wide margin. Despite year-over-year revenue growth of 27% and improvements in gross profit and operating loss, adjusted EBITDA remained negative at -$1.3 million and the net loss was $21.7 million. The shares plunged about 20% after the announcement but showed slight recovery in premarket trading. Management emphasizes a focus on renewable fuels projects but sees ongoing execution and profitability risks. » Mere på de.investing.com


  • Aemetis misses Q1 2026 forecasts, stock down in premarket

    Aemetis reported Q1 2026 earnings per share of -$0.33 (expectation -$0.28) and revenue of $54.6 million versus forecasted $69.4 million. Revenue rose 27% year‑on‑year and gross profit improved to $2.8 million (prior year gross loss $5.1 million), but the missed numbers sent the stock down 4.6% in premarket trading. The company still expects quarterly losses, but sees improvements by fiscal 2027 and is counting on expanding RNG projects and securing new LCFS certifications to boost profitability. » Mere på de.investing.com

Virksomhedstal

I det seneste kvartal havde Aemetis en omsætning på 77,83 mio. € og et nettoresultat på 4,6 mio. €
(EUR) september 2026
YoY
Omsætning 77,83 mio. 54,30 %
Bruttofortjeneste 26,02 mio. 52.747,48 %
Nettoresultat 4,6 mio. 122,73 %
EBITDA 20,69 mio. 478,16 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
79,62 mio. €
Antal aktier
73,1 mio.
Højeste/laveste i 52 uger
3,45 € - 1,01 €
Udbytte Nej
Beta
1,47
P/E (PE Ratio)
-2,55
PEG (PEG Ratio)
-0,02
K/I (PB Ratio)
0,00
P/S (PS Ratio)
0,34

Virksomhedsprofil

Aemetis, Inc. driver virksomhed inden for vedvarende naturgas og vedvarende brændstoffer i Nordamerika og Indien. Virksomheden opererer gennem tre segmenter: California Ethanol, Dairy Renewable Natural Gas og India Biodiesel. Virksomheden fokuserer på opkøb, udvikling og kommercialisering af produkter og teknologier med negativ kulstofintensitet, som erstatter traditionelle produkter baseret på fossil olie. Den sælger biodiesel primært til statslige olieselskaber, transportvirksomheder, videresælgere, distributører og private raffinaderier gennem sin egen salgsstyrke og uafhængige salgsagenter, samt til mæglere, som videresælger produktet til slutbrugere. Virksomheden producerer og sælger også ethanol; samt våde destillerede kornrester, destilleret majsolie og kondenserede destillerede opløselige stoffer til mejerier og foderbedrifter som dyrefoder. Derudover producerer den biogas fra mejerier; producerer og sælger højkvalitetsalkohol og forskellige foderprodukter samt håndsprit; og forsker i og udvikler konverteringsteknologier, der anvender affaldsråstoffer til at producere biobrændstoffer og biokemikalier. Virksomheden var tidligere kendt som AE Biofuels, Inc. og skiftede navn til Aemetis, Inc. i november 2011. Aemetis, Inc. blev grundlagt i 2005 og har hovedkontor i Cupertino, Californien.

Navn
Aemetis
CEO
Eric A. McAfee
Hjemsted Cupertino, ca
USA
Websted
Sektor
Energi
Branche
Olie, gas og ikke-vedvarende brændstoffer
Børsnotering
27.06.2006
Medarbejdere 220

Tickersymboler

Børs Symbol
NASDAQ
AMTX
Frankfurt
DW51.F
Düsseldorf
DW51.DU
München
DW51.MU
🍪

Parqet  bruger cookies. Læs mere